News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Trump and Putin held an 85-minute call on Ukraine, Iran, and NATO logistics, adding geopolitical risk ahead of the Ankara NATO summit.
  • Australia formalized a security partnership with Fiji and a uranium export deal with India, strengthening regional defense and energy links.
  • Investors rotated into Indian equities amid AI-led rally strains, favoring calmer trading and improving macro fundamentals.
  • WhiteFiber (WYFI), a small-cap AI colo operator, pulled back into the low $30s and trades as a leveraged play on AI power capacity.
  • New Zealand's National Party pledged seven new free-trade talks within five years, signaling a pro-trade economic agenda if elected.

Latest Articles

Primoris Shares Plummet After Sweeping 2026 Outlook Cut and COO Exit

Primoris Shares Plummet After Sweeping 2026 Outlook Cut and COO Exit

Primoris Services Corporation stock fell sharply in pre-market trading after the Dallas-based contractor sharply reduced its 2026 adjusted EBITDA and EPS guidance, attributed to cost overruns and schedule delays on six Renewables projects. The company also disclosed the immediate departure of its COO, prompting analyst downgrades and renewed invest…

Webull Opens Platform to Late-Stage Private Deals via Monark-Sponsored SPVs

Webull Opens Platform to Late-Stage Private Deals via Monark-Sponsored SPVs

Webull is introducing a private markets capability that will allow accredited investors on its platform to access late-stage private companies through special purpose vehicles (SPVs) sponsored by Monark Capital Management. The offering uses Monark Markets' infrastructure to source and structure single-company vehicles, with investor interest signal…

ASP Isotopes Inc. Announces that a Subsidiary of Renergen Limited Has Entered into its First Take-or-Pay Contract for the Supply of Contained Helium to be Produced at the Virginia Gas Project in South Africa

ASP Isotopes Inc. Announces that a Subsidiary of Renergen Limited Has Entered into its First Take-or-Pay Contract for the Supply of Contained Helium to be Produced at the Virginia Gas Project in South Africa

ASP Isotopes Inc. announced that its subsidiary Renergen Limited's Tetra4 has entered into its first five-year take-or-pay contract to supply contained helium to an Asian industrial gases company from the Virginia Gas Project in South Africa. Phase 1 commercial operations remain targeted for Q3 2026, with helium sales priced above $600/MCF. Phase 2…

Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

Galectin Therapeutics announced positive feedback from its Type C meeting with the FDA, securing agreement on the primary endpoint and regulatory path for belapectin's Phase 3 trial targeting metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and portal hypertension. The Phase 3 protocol filing is planned for Q3 2026, with strategic …

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Kalaris Therapeutics, a clinical-stage biopharmaceutical company, announced it will present Phase 1a clinical data of its novel dual-targeting biologic TH103 at the American Society of Retina Specialists 2026 Annual Meeting. The company is actively enrolling patients in its Phase 1b/2 trial for TH103 targeting neovascular Age-related Macular Degene…

From the pitch to the airport: Cristiano Ronaldo and Vini Jr. chosen as Brazil’s dream travel buddies, reveals KAYAK

From the pitch to the airport: Cristiano Ronaldo and Vini Jr. chosen as Brazil’s dream travel buddies, reveals KAYAK

KAYAK, a travel search engine under Booking Holdings, surveyed 2,000 Brazilian travelers to identify which football players they most want to travel with, with Cristiano Ronaldo leading at 60%. The Northeast region of Brazil, particularly Bahia, was the preferred destination. The survey insights aim to influence travel plans and promote destination…

ZenaTech Expands Drone as a Service Platform with 24th Acquisition, Adding Green Earth Powerwashing Franchise Network

ZenaTech Expands Drone as a Service Platform with 24th Acquisition, Adding Green Earth Powerwashing Franchise Network

ZenaTech, a Nasdaq-listed technology company specializing in AI-powered drones and Drone as a Service (DaaS), has acquired Green Earth Powerwashing LLC, a Florida-based franchise providing exterior cleaning and property maintenance services. This 24th acquisition strengthens ZenaTech's footprint in Florida and integrates drone-powered cleaning into…

Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.

Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.

Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) has formed a strategic partnership with Hong Kong-listed Cloud Factory Technology Holdings Limited to co-develop an AI-driven ecosystem aimed at transforming the beauty industry through improved operational efficiency, digital tools, and smart resource utilization. The collaboration leverages C…

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

Calidi Biotherapeutics has announced the appointment of Corsee Sanders, Ph.D., a seasoned biopharma executive with leadership experience at Genentech/Roche and Celgene, to its Board of Directors. Dr. Sanders' expertise is expected to support Calidi's clinical advancement of its RedTail platform and lead candidate CLD-401 targeting multiple cancers.…

One Stop Systems Set to Join US Small-Cap Russell 2000® Index

One Stop Systems Set to Join US Small-Cap Russell 2000® Index

One Stop Systems, Inc., a leader in rugged high-performance compute solutions for AI and edge applications, announced its anticipated inclusion in the US small-cap Russell 2000® Index effective June 29, 2026. This milestone recognizes the company's growth strategy execution and is expected to enhance its access to passive and active institutional i…

Exyn Technologies Rebrands Range Subsidiary as Exyn Defense

Exyn Technologies Rebrands Range Subsidiary as Exyn Defense

Exyn Technologies has rebranded its defense-focused subsidiary, Range, as Exyn Defense, Inc. This move aligns its government and defense operations under the Exyn brand to better target autonomous autonomy and mapping software solutions for GPS-denied and high-risk environments. Exyn Defense aims to leverage the company's proven ExynAI technology t…

Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer

Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer

Provident Bank appointed Adriano Duarte as Executive Vice President and Chief Financial Officer, effective July 1, 2026. Duarte, with over 30 years of banking experience, previously served as EVP and Chief Accounting Officer and will lead key financial functions to support growth and financial performance at Provident Bank and its parent company, P…

Integra LifeSciences Announces Key Executive Appointments

Integra LifeSciences Announces Key Executive Appointments

Integra LifeSciences Corporation Holdings announced a series of leadership changes within its commercial organization, including new appointments and promotions aimed at enhancing customer focus, accelerating execution, and supporting the company’s long-term growth strategy. These changes involve executives leading key divisions such as Tissue Reco…

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

INmune Bio secured written alignment from the UK MHRA on its development and regulatory strategy for CORDStrom™ (Ebstrocel™) targeting Recessive Dystrophic Epidermolysis Bullosa (RDEB). The guidance clarifies manufacturing, safety, and clinical evidence requirements and supports a 2026 conditional marketing authorization submission in the UK, with …

Two-Thirds of Consumers Are Ready to Try Agentic Shopping, but Many Demand Human Approval Before AI Can Buy

Two-Thirds of Consumers Are Ready to Try Agentic Shopping, but Many Demand Human Approval Before AI Can Buy

Commerce (Nasdaq: CMRC) released a research study revealing that two-thirds of consumers across the US, UK, and Australia are interested in trying AI-powered agentic shopping tools that assist with product discovery, comparison, and purchasing. While enthusiasm is high, consumers emphasize the need for transparency, security, and human approval in …

Airship AI Secures Seven Figure Follow-On Contract Award with Fortune 100 Transportation & E-Commerce Company

Airship AI Secures Seven Figure Follow-On Contract Award with Fortune 100 Transportation & E-Commerce Company

Airship AI Holdings announced a significant one-year contract extension worth $1.9 million with an existing Fortune 100 transportation and e-commerce client for maintenance and sustainment of its Acropolis Enterprise Video and Data Management platform. The company also received additional smaller orders totaling $1.4 million, enhancing its recurrin…

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

Revolution Medicines has announced the commencement of patient treatment in RASolute 305, a global Phase 3 randomized trial evaluating zoldonrasib combined with standard chemotherapy as a first-line treatment in metastatic RAS G12D pancreatic ductal adenocarcinoma (PDAC). Building on previous positive data with their RAS(ON) inhibitors, this trial …

VisionWave Unveils Combat-Ready TALON™ and D-FLY™ Autonomous Drone Platforms at Eurosatory 2026, Expanding STRATUM™ Battlefield Autonomy Ecosystem

VisionWave Unveils Combat-Ready TALON™ and D-FLY™ Autonomous Drone Platforms at Eurosatory 2026, Expanding STRATUM™ Battlefield Autonomy Ecosystem

VisionWave Holdings, Inc. introduced two new autonomous drone platforms, TALON™ Tactical Autonomous Aerial System and D-FLY™ Autonomous Intercept Platform, at Eurosatory 2026. These platforms expand VisionWave's STRATUM™ battlefield autonomy ecosystem, demonstrating integrated AI-driven autonomous capabilities for ISR, counter-UAS, communications r…

64% of UK Consumers Want to Use Agentic AI for Shopping, According to New Research from Commerce and PayPal

64% of UK Consumers Want to Use Agentic AI for Shopping, According to New Research from Commerce and PayPal

Commerce and PayPal released a research study revealing 64% of UK consumers are interested in using agentic AI tools for shopping, which assist in product research, comparison, and purchasing. While adoption is nascent, most consumers desire AI to facilitate better deals and discounts but prefer to retain control over purchase decisions. The study …